Researchers are exploring the potential of a type 2 diabetes drug to treat autoimmune disorders. This drug, originally developed for diabetes management, may have beneficial effects in modulating the immune system and reducing the harmful responses seen in autoimmune conditions. While this research is promising, further studies and clinical trials are needed to confirm its effectiveness and safety for treating autoimmune diseases.